We are live on ! Find out more
CF

CNA Financial Portfolio holdings

AUM $239M
1-Year Est. Return 4.56%
This Fund
S&P 500
This Quarter Est. Return
-2.39%
1 Year Est. Return
+4.56%
3 Year Est. Return
+48.61%
5 Year Est. Return
+65.51%
10 Year Est. Return
+269.22%
AUM
$263M
AUM Growth
-$23.1M
Cap. Flow
-$8.07M
Cap. Flow %
-3.07%
Top 10 Hldgs %
44.78%
Holding
186
New
13
Increased
26
Reduced
122
Closed
19

Sector Composition

Rank Sector Weight
1 Healthcare 18.86%
2 Energy 15.97%
3 Technology 13.92%
4 Consumer Discretionary 10.15%
5 Materials 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOVE
151
LoveSac
LOVE
$199M
$250K 0.1%
12,269
-7,002
-36% -$215K
RH icon
152
RH
RH
$2.49B
$248K 0.09%
+1,009
New +$272K
ENFN
153
DELISTED
Enfusion, Inc.
ENFN
$248K 0.09%
20,099
-2,660
-12% -$32.4K
YMAB
154
DELISTED
Y-mAbs Therapeutics
YMAB
$241K 0.09%
16,720
-7,190
-30% -$119K
SYNA icon
155
Synaptics
SYNA
$3.75B
$237K 0.09%
2,395
-3,760
-61% -$467K
RLAY icon
156
Relay Therapeutics
RLAY
$4.24B
$235K 0.09%
10,499
-5,250
-33% -$115K
VITL icon
157
Vital Farms
VITL
$430M
$233K 0.09%
19,487
-2,210
-10% -$26.4K
ZNTL icon
158
Zentalis Pharmaceuticals
ZNTL
$331M
$228K 0.09%
10,516
-1,170
-10% -$32K
DKNG icon
159
DraftKings
DKNG
$12.1B
$223K 0.08%
14,722
-845
-5% -$13.4K
NVEI
160
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
$222K 0.08%
+8,202
New +$268K
RARE icon
161
Ultragenyx Pharmaceutical
RARE
$1.37B
$220K 0.08%
5,310
+420
+9% +$21.6K
VIR icon
162
Vir Biotechnology
VIR
$1.84B
$197K 0.07%
10,192
-3,500
-26% -$89K
AZEK
163
DELISTED
The AZEK Co
AZEK
$194K 0.07%
11,683
-37,653
-76% -$716K
SMRT icon
164
SmartRent
SMRT
$224M
$158K 0.06%
69,750
-23,997
-26% -$94.7K
ERAS icon
165
Erasca
ERAS
$5.75B
$150K 0.06%
19,197
-2,170
-10% -$17.5K
ADCT icon
166
ADC Therapeutics
ADCT
$137M
$67K 0.03%
13,945
-1,570
-10% -$11.4K
XWEL icon
167
XWELL
XWEL
$7.99M
$24K 0.01%
1,568
CERT icon
168
Certara
CERT
$1.17B
-28,374
Closed -$609K
CI icon
169
Cigna
CI
$76.3B
-37,500
Closed -$9.88M
FRPT icon
170
Freshpet
FRPT
$3.11B
-11,150
Closed -$579K
HAYW icon
171
Hayward Holdings
HAYW
$2.77B
-47,646
Closed -$686K
HCAT icon
172
Health Catalyst
HCAT
$131M
-39,530
Closed -$573K
KRNT icon
173
Kornit Digital
KRNT
$673M
-12,624
Closed -$400K
LBRDK
174
DELISTED
Liberty Broadband Class C
LBRDK
-3,217
Closed -$372K
LOB icon
175
Live Oak Bancshares
LOB
$1.83B
-13,200
Closed -$447K

Similar funds

CNA Financial's Q3 2022 Portfolio in Review

As of Q3 2022, CNA Financial held 186 positions worth $263M, down 8.1% from $286M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

CNA Financial withdrew a net $8.07M in Q3 2022, closing 19 positions and reducing 122 holdings. Its most notable exit was Cigna, an estimated $9.88M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 22% a quarter earlier, followed by Energy and Technology.

Against the trend, CNA Financial opened a new position in Devon Energy worth $4.51M.

  • CNA Financial's largest Q3 2022 buy was Devon Energy: 75,000 shares worth $4.51M.
  • CNA Financial added most to Meta Platforms (Facebook) in Q3 2022, an estimated $3.24M increase.
  • CNA Financial's biggest Q3 2022 reduction was Ferguson, cutting an estimated $4.08M.
  • CNA Financial fully exited Cigna in Q3 2022, selling an estimated $9.88M.
  • CNA Financial's ten largest holdings make up 45% of its $263M portfolio in Q3 2022.
  • CNA Financial opened 13 new positions and closed 19 in Q3 2022.
  • CNA Financial's portfolio value fell 8.1% quarter-over-quarter to $263M.

Based on CNA Financial's 13F filing for Q3 2022, filed 10 Nov 2022.